These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Epidemiology of pemphigus in south-western Iran: a 10-year retrospective study (1991-2000). Salmanpour R; Shahkar H; Namazi MR; Rahman-Shenas MR Int J Dermatol; 2006 Feb; 45(2):103-5. PubMed ID: 16445496 [TBL] [Abstract][Full Text] [Related]
7. Value of direct immunofluorescence in predicting remission in pemphigus vulgaris. Balighi K; Taheri A; Mansoori P; Chams C Int J Dermatol; 2006 Nov; 45(11):1308-11. PubMed ID: 17076711 [TBL] [Abstract][Full Text] [Related]
8. Pemphigus and associated environmental factors: a case-control study. Valikhani M; Kavusi S; Chams-Davatchi C; Daneshpazhooh M; Barzegari M; Ghiasi M; Abedini R Clin Exp Dermatol; 2007 May; 32(3):256-60. PubMed ID: 17355277 [TBL] [Abstract][Full Text] [Related]
9. Role of thiopurine methyltransferase activity in the safety and efficacy of azathioprine in the treatment of pemphigus vulgaris. Firooz A; Ghandi N; Hallaji Z; Chams-Davatchi C; Valikhani M; Karbakhsh Davari M Arch Dermatol; 2008 Sep; 144(9):1143-7. PubMed ID: 18794458 [TBL] [Abstract][Full Text] [Related]
10. Improved protocol for treatment of pemphigus vulgaris with protein A immunoadsorption. Shimanovich I; Herzog S; Schmidt E; Opitz A; Klinker E; Bröcker EB; Goebeler M; Zillikens D Clin Exp Dermatol; 2006 Nov; 31(6):768-74. PubMed ID: 16824051 [TBL] [Abstract][Full Text] [Related]
11. Pemphigus: analysis of 1209 cases. Chams-Davatchi C; Valikhani M; Daneshpazhooh M; Esmaili N; Balighi K; Hallaji Z; Barzegari M; Akhiani M; Ghodsi Z; Mortazavi H; Naraghi Z Int J Dermatol; 2005 Jun; 44(6):470-6. PubMed ID: 15941433 [TBL] [Abstract][Full Text] [Related]
12. Pemphigus vulgaris in Iran: a clinical study of 140 cases. Esmaili N; Chams-Davatchi C; Valikhani M; Daneshpazhooh M; Balighi K; Hallaji Z; Barzegari M; Akhyani M; Ghodsi ZS; Mrotazavi H; Naraghi ZS; Toosi S Int J Dermatol; 2007 Nov; 46(11):1166-70. PubMed ID: 17988336 [TBL] [Abstract][Full Text] [Related]
13. Pemphigus in Israel--an epidemiologic analysis of cases in search of risk factors. Wohl Y; Brenner S Isr Med Assoc J; 2003 Jun; 5(6):410-2. PubMed ID: 12841011 [TBL] [Abstract][Full Text] [Related]
14. Cutaneous pemphigus vulgaris with skin features similar to the classic mucocutaneous type: a case report and review of the literature. Shinkuma S; Nishie W; Shibaki A; Sawamura D; Ito K; Tsuji-Abe Y; Natsuga K; Chan PT; Amagai M; Shimizu H Clin Exp Dermatol; 2008 Nov; 33(6):724-8. PubMed ID: 18627395 [TBL] [Abstract][Full Text] [Related]
15. Epidemiology of pemphigus in the western region of Turkey: retrospective analysis of 87 patients. Bozdag K; Bilgin İ Cutan Ocul Toxicol; 2012 Dec; 31(4):280-5. PubMed ID: 22309241 [TBL] [Abstract][Full Text] [Related]
16. ELISA testing of anti-desmoglein 1 and 3 antibodies in the management of pemphigus. Abasq C; Mouquet H; Gilbert D; Tron F; Grassi V; Musette P; Joly P Arch Dermatol; 2009 May; 145(5):529-35. PubMed ID: 19451496 [TBL] [Abstract][Full Text] [Related]
17. Pemphigus vulgaris and pemphigus foliaceus: similar prognosis? Zaraa I; Mokni M; Hsairi M; Boubaker S; Sellami M; Zitouni M; Makni S; Dhahri AB Int J Dermatol; 2007 Sep; 46(9):923-6. PubMed ID: 17822493 [TBL] [Abstract][Full Text] [Related]
18. Two courses of rituximab (anti-CD20 monoclonal antibody) for recalcitrant pemphigus vulgaris. Faurschou A; Gniadecki R Int J Dermatol; 2008 Mar; 47(3):292-4. PubMed ID: 18289336 [TBL] [Abstract][Full Text] [Related]
19. Quality-of-life assessment in patients with pemphigus using a minimum set of evaluation tools. Paradisi A; Sampogna F; Di Pietro C; Cianchini G; Didona B; Ferri R; Abeni D; Tabolli S J Am Acad Dermatol; 2009 Feb; 60(2):261-9. PubMed ID: 19004524 [TBL] [Abstract][Full Text] [Related]
20. Cigarette smoking and sarcoidosis. Peros-Golubicić T; Ljubić S Acta Med Croatica; 1995; 49(4-5):187-93. PubMed ID: 8630452 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]